182 related articles for article (PubMed ID: 24774305)
21. New drugs: ambrisentan, temsirolimus, and eculizumab.
Hussar DA
J Am Pharm Assoc (2003); 2007; 47(5):664, 666-7, 669-71. PubMed ID: 17848357
[No Abstract] [Full Text] [Related]
22. The status of pulmonary arterial hypertension in 2008.
Farber HW
Circulation; 2008 Jun; 117(23):2966-8. PubMed ID: 18541751
[No Abstract] [Full Text] [Related]
23. Treatment of newly diagnosed sarcoid-associated pulmonary hypertension with ambrisentan and tadalafil combination therapy.
Abston E; Hon S; Lawrence R; Berman J; Govender P; Farber HW
Sarcoidosis Vasc Diffuse Lung Dis; 2020; 37(2):234-238. PubMed ID: 33093789
[TBL] [Abstract][Full Text] [Related]
24. [Effects of ambrisentan in treatment of pulmonary arterial hypertension: a pilot study with 15 patients].
He J; Wen L; Jiang R; Zhao QH; Wang L; Jiang X; Yan P; Bai L; Jing ZC
Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Jun; 41(6):493-6. PubMed ID: 24113042
[TBL] [Abstract][Full Text] [Related]
25. [Digital ulcers in systemic sclerosis].
Guillevin L
Presse Med; 2008 Apr; 37(4 Pt 2):735-6. PubMed ID: 18258409
[No Abstract] [Full Text] [Related]
26. Pharmacokinetic evaluation of ambrisentan.
Buckley MS; Wicks LM; Staib RL; Kirejczyk AK; Varker AS; Gibson JJ; Feldman JP
Expert Opin Drug Metab Toxicol; 2011 Mar; 7(3):371-80. PubMed ID: 21299444
[TBL] [Abstract][Full Text] [Related]
27. Successful treatment of systemic sclerosis digital ulcers and pulmonary arterial hypertension with endothelin receptor antagonist bosentan.
Humbert M; Cabane J
Rheumatology (Oxford); 2003 Jan; 42(1):191-3. PubMed ID: 12509640
[No Abstract] [Full Text] [Related]
28. Safety and efficacy evaluation of ambrisentan in pulmonary hypertension.
Vizza CD; Fedele F; Pezzuto B; Rubin LJ
Expert Opin Drug Saf; 2012 Nov; 11(6):1003-11. PubMed ID: 22861496
[TBL] [Abstract][Full Text] [Related]
29. Early treatment with ambrisentan of mildly elevated mean pulmonary arterial pressure associated with systemic sclerosis: a randomized, controlled, double-blind, parallel group study (EDITA study).
Pan Z; Marra AM; Benjamin N; Eichstaedt CA; Blank N; Bossone E; Cittadini A; Coghlan G; Denton CP; Distler O; Egenlauf B; Fischer C; Harutyunova S; Xanthouli P; Lorenz HM; Grünig E
Arthritis Res Ther; 2019 Oct; 21(1):217. PubMed ID: 31655622
[TBL] [Abstract][Full Text] [Related]
30. Improvement in Right Ventricular Strain with Ambrisentan and Tadalafil Upfront Therapy in Scleroderma-associated Pulmonary Arterial Hypertension.
Mercurio V; Mukherjee M; Tedford RJ; Zamanian RT; Khair RM; Sato T; Minai OA; Torres F; Girgis RE; Chin K; Damico R; Kolb TM; Mathai SC; Hassoun PM
Am J Respir Crit Care Med; 2018 Feb; 197(3):388-391. PubMed ID: 28661697
[No Abstract] [Full Text] [Related]
31. Ambrisentan use for pulmonary arterial hypertension in a post-authorization drug registry: The VOLibris Tracking Study.
Vachiéry JL; Hoeper MM; Peacock AJ; Sitbon O; Cheli M; Church C; Olsson KM; Palazzini M; Waterhouse B; Langley J; Galié N
J Heart Lung Transplant; 2017 Apr; 36(4):399-406. PubMed ID: 27282418
[TBL] [Abstract][Full Text] [Related]
32. [A case of systemic sclerosis in childhood complicated by severe digital ulcers].
Falcini F; Volpi M; Pierattelli M; Taccetti G; Pratesi G; Matucci Cerinich M
Pediatr Med Chir; 1984; 6(5):703-7. PubMed ID: 6535137
[TBL] [Abstract][Full Text] [Related]
33. Role of ambrisentan in the management of pulmonary hypertension.
Hrometz SL; Shields KM
Ann Pharmacother; 2008 Nov; 42(11):1653-9. PubMed ID: 18957622
[TBL] [Abstract][Full Text] [Related]
34. Ambrisentan for sarcoidosis associated pulmonary hypertension.
Judson MA; Highland KB; Kwon S; Donohue JF; Aris R; Craft N; Burt S; Ford HJ
Sarcoidosis Vasc Diffuse Lung Dis; 2011 Oct; 28(2):139-45. PubMed ID: 22117505
[TBL] [Abstract][Full Text] [Related]
35. Pulmonary hypertension complicating connective tissue disease.
Lynch JP; Belperio JA; Saggar R; Fishbein MC; Saggar R
Semin Respir Crit Care Med; 2013 Oct; 34(5):581-99. PubMed ID: 24037627
[TBL] [Abstract][Full Text] [Related]
36. Pulmonary hypertension in systemic sclerosis: bete noire no more?
Varga J
Curr Opin Rheumatol; 2002 Nov; 14(6):666-70. PubMed ID: 12410089
[No Abstract] [Full Text] [Related]
37. Ambrisentan May Improve Exercise Tolerance and Cardiac Function in Patients With Pulmonary Hypertension.
Li XQ; Li YJ; Wang Y
Clin Ther; 2015 Jun; 37(6):1270-9. PubMed ID: 25862136
[TBL] [Abstract][Full Text] [Related]
38. Ambrisentan use in a HIV-1 infected patient with end-stage renal disease and pulmonary hypertension: minimal removal by hemodialysis - a case report.
Santos JR; Merino A; Haefeli WE; Miranda C; Prats M; Bancu I; Bailón L; Moltó J
BMC Nephrol; 2020 Jan; 21(1):24. PubMed ID: 31992232
[TBL] [Abstract][Full Text] [Related]
39. Systemic lupus erythematosus, complicated with refractory skin ulcers, treated successfully with bosentan.
Suzuki E; Kyozuka H; Nishida T; Kanno T; Ohira H
Mod Rheumatol; 2009; 19(4):447-51. PubMed ID: 19504167
[TBL] [Abstract][Full Text] [Related]
40. Ambrisentan (Letairis) for pulmonary arterial hypertension.
Med Lett Drugs Ther; 2007 Oct; 49(1272):87-8. PubMed ID: 17938611
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
